The results of concomitant and sequential chemoradiotherapy with cisplatin and etoposide in patients with locally advanced non-small cell lung cancer

Journal of B.U.ON.

Volumn 10, Issue 2, 2005, Pages 213-218

  Saynak, Mert ^a,d   Aksu, G ^b   Fayda, M ^c   Kaytan, E ^c   Oral, E ^c   Gurocak, S ^c   Kizir, A ^c   Karadeniz, A ^c  

^a SELCUK UNIVERSITY   (Turkey)

^b KOCAELI UNIVERSITY   (Turkey)

^c ISTANBUL UNIVERSITY   (Turkey)

^d NONE   (Turkey)

Author keywords

Chemoradiotherapy; Concomitant; Non small cell lung cancer; Sequential

Indexed keywords

CISPLATIN; ETOPOSIDE;

ADULT; ADVANCED CANCER; AGED; ANEMIA; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; ESOPHAGITIS; FEMALE; HUMAN; LARGE CELL CARCINOMA; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; NEPHROTOXICITY; NEUTROPENIA; PROGNOSIS; RADIATION DOSE; RADIATION PNEUMONIA; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME; WEIGHT REDUCTION;

EID: 24944536598     PISSN: 11070625     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Franceschi S, Bidoli E. The epidemiology of lung cancer. Ann Oncol 1999; 10: 53-56.
2. Le Chevalier T, Arriagada R, Quoix E et al. Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small cell lung cancer: first analysis of a randomized trial in 353 patients. J Natl Cancer Inst 1991; 83: 417-423.
3. Morton RF, Jett JR, McGinnis WL et al. Thoracic radiation therapy alone compared with combined chemoradiotherapy for locally unresectable non-small cell lung cancer. A randomized, phase III trial. Ann Intern Med 1991; 115: 681-686.
4. Dillman RO, Seagren SL, Propert KJ et al. A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small cell lung cancer. N Engl J Med 1990; 323: 940-945.
5. Schaake-Koning C, van den Bogaert W, Dalesio O et al. Effects of concomitant cisplatin and radiotherapy on inoperable non-small cell lung cancer. N Engl J Med 1992; 326: 524-530.
6. Sause WT, Scott C, Taylor S et al. Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: preliminary results of a phase III trial in regionally advanced, unresectable non-small cell lung cancer. J Natl Cancer Inst 1995; 87: 198-205.
7. Mountain CF. Revisions in the International System for Staging Lung Cancer. Chest 1997; 111: 1710-1717.
8. Deslauriers J, Brisson J, Cartier R et al. Carcinoma of the lung: evaluation of satellite nodules as a factor influencing prognosis after resection. Thorac Cardiovasc Surg 1989; 97: 504-512.
9. Urschel JD, Urschel DM, Anderson TM et al. Prognostic implications of pulmonary satellite nodules: are the 1997 staging revisions appropriate? Lung Cancer 1998; 21: 83-87.
10. Darteville PG, Khalife J, Chapelier A et al. Tracheal sleeve pneumonectomy for bronchogenic carcinoma: a report of 55 cases. Ann Thorac Surg 1988; 46: 68-72.
11. Albain KS, Rusch VW, Crowley JJ et al. Concurrent cisplatin/etoposide plus chest radiation therapy followed by surgery for stage IIIA (N2) and IIIB non-small cell lung cancer: mature results of Southwest Oncology Group Phase II Study 8805. J Clin Oncol 1995; 13: 1880-1892.
12. Sause W, Kolesar P, Taylor SI et al. Final results of phase III trial in regionally advanced unresectable non-small cell lung cancer: Radiation Therapy Oncology Group, Eastern Cooperative Oncology Group, and Southwest Oncology Group. Chest 2000; 117: 358-364.
13. Dillman RO, Herndon J, Seagren SL et al. Improved survival in stage III non-small cell lung cancer: Seven-year follow-up of cancer and leukemia group B (CALGB) 8433 trial. J Natl Cancer Inst 1996; 88: 1210-1215.
14. Komaki R, Scott CB, Sause WT et al. Induction cisplatin/vinblastine and irradiation vs. irradiation in unresectable squamous cell lung cancer: Failure patterns by cell type in RTOG 88-08/ECOG 4588 - Radiation Therapy Oncology Group, Eastern Cooperative Oncology Group. Int J Radiat Oncol Biol Phys 1997; 39: 537-544.
15. Anonymous. Chemotherapy for non-small cell lung cancer: Non-Small Cell Lung Cancer Collaborative Group. Cochrane Database of Systematic Reviews: CD002139, 2000.
16. Curran WJ Jr, Scott C, Langer C et al. Phase III comparison of sequential vs. concurrent chemoradiation for patients with unresected stage III non-small cell lung cancer (NSCLC): Initial report of Radiation Therapy Oncology Group (RTOG) 9410. Proc Am Soc Clin Oncol 2000; 19: 484 (abstr 1891).
17. Furuse K, Fukuoka M, Kawahara M et al. Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small cell lung cancer. J Clin Oncol 1999; 17: 2692-2699.
18. Belani CP. Incorporation of paclitaxel and carboplatin in combined-modality therapy for locally advanced non-small cell lung cancer. Semin Oncol 1999; 26: 44-54.
19. Masters GA, Haraf DJ, Hoffman PC et al. Phase I study of vinorelbine, cisplatin, and concomitant thoracic radiation in the treatment of advanced chest malignancies. J Clin Oncol 1998; 16: 2157-2163.
20. Vokes EE, Herndon JE II, Crawford J et al. Randomized phase II study of cisplatin with gemcitabine or paclitaxel or vinorelbine as induction chemotherapy followed by concomitant chemoradiotherapy for stage IIIB non-small cell lung cancer: Cancer and Leukemia Group B study 9431. J Clin Oncol 2002; 20: 4191-4198.
21. Clamon G, Herndon J, Cooper R et al. Radiosensitization with carboplatin for patients with unresectable stage III non-small cell lung cancer: A phase III trial of the Cancer and Leukemia Group B and the Eastern Cooperative Oncology Group. J Clin Oncol 1999; 17: 4-11.
22. Rusch VW, Giroux DJ, Kraut MJ et al. Induction chemoradiation and surgical resection for non-small cell lung carcinomas of the superior sulcus: Initial results of Southwest Oncology Group Trial 9416 (Intergroup Trial 0160). J Thorac Cardiovasc Surg 2001; 121: 472-483.
23. Veronesi G, Solli PG, Leo F et al. Low morbidity of bronchoplastic procedures after chemotherapy for lung cancer. Lung Cancer 2002; 36: 91-97.
24. Rosell R, Gomez-Codina J, Camps C et al. Preresectional chemotherapy in stage IIIA non-small cell lung cancer: A 7-year assessment of a randomized controlled trial. Lung Cancer 1999; 26: 7-14.
25. Roth JA, Fossella F, Komaki R et al. A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small cell lung cancer. J Natl Cancer Inst 1994; 86: 673-680.
26. Roth JA, Atkinson EN, Fossella F et al. Long-term follow-up of patients enrolled in a randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small cell lung cancer. Lung Cancer 1998; 21: 1-6.
27. Saunders M, Dische S, Barrett A et al. Continuous hyperfractionated accelerated radiotherapy (CHART) vs. conventional radiotherapy in non-small cell lung cancer: a randomized multicentre trial. Lancet 1997; 350: 161-165.
28. Saunders M, Dische S, Barrett A et al. Continuous, hyperfractionated, accelerated radiotherapy (CHART) vs. conventional radiotherapy in non-small cell lung cancer: mature data from the randomized multicentre trial. Radiother Oncol 1999; 52: 137-148.
29. Oral EN, Bavbek S, Kizir A et al. Preliminary analysis of a phase II study of paclitaxel and CHART in locally advanced non-small cell lung cancer. Lung Cancer 1999; 25: 191-198.